Skip to main content

ORIGINAL RESEARCH article

Front. Aging Neurosci., 11 August 2022
Sec. Alzheimer's Disease and Related Dementias
Volume 14 - 2022 | https://doi.org/10.3389/fnagi.2022.960246

RETRACTED: QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics

Deepshi Arora1,2 Shailendra Bhatt3 Manish Kumar1* Ravinder Verma3 Yugam Taneja4 Nikita Kaushal1 Abhishek Tiwari5 Varsha Tiwari5 Athanasios Alexiou6,7 Sarah Albogami8 Saqer S. Alotaibi8 Vineet Mittal9 Rajeev K. Singla10,11 Deepak Kaushik9* Gaber El-Saber Batiha12*
  • 1M.M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Ambala, Haryana, India
  • 2Guru Gobind Singh College of Pharmacy, Yamuna Nagar, Haryana, India
  • 3Department of Pharmacy, G.D. Goenka University, Gurugram, Haryana, India
  • 4Zeon Lifesciences Pvt. Ltd., Paonta Sahib, Himachal Pradesh, India
  • 5Pharmacy Academy, IFTM University, Moradabad, UP, India
  • 6Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, NSW, Australia
  • 7AFNP Med Austria, Wien, Austria
  • 8College of Science, Taif University, Taif, Saudi Arabia
  • 9Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India
  • 10Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China
  • 11iGlobal Research and Publishing Foundation, New Delhi, India
  • 12Faculty of Veterinary Medicine, Department of Pharmacology and Therapeutics, Damanhour University, Damanhour, Egypt

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Arora D, Bhatt S, Kumar M, Verma R, Taneja Y, Kaushal N, Tiwari A, Tiwari V, Alexiou A, Albogami S, Alotaibi SS, Mittal V, Singla RK, Kaushik D and Batiha G-S (2022) QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics. Front. Aging Neurosci. 14:960246. doi: 10.3389/fnagi.2022.960246

Received: 02 June 2022; Accepted: 14 July 2022;
Published: 11 August 2022; Retracted: 28 March 2024.

Edited by:

Patrick R. Hof, Icahn School of Medicine at Mount Sinai, United States

Reviewed by:

Ashok Iyaswamy, Hong Kong Baptist University, Hong Kong SAR, China
Simona Cavalu, University of Oradea, Romania
Download